These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26165848)

  • 21. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.
    Patil H; Tiwari RV; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):20-42. PubMed ID: 26159653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
    van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
    Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.
    van Hoogevest P; Liu X; Fahr A
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1481-500. PubMed ID: 21895540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of bacterial cellulose-based drug delivery systems: their biochemistry, current approaches and future prospects.
    Abeer MM; Mohd Amin MC; Martin C
    J Pharm Pharmacol; 2014 Aug; 66(8):1047-61. PubMed ID: 24628270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in pediatric drug development: a pharmaceutical industry perspective.
    Rose K
    Paediatr Drugs; 2009; 11(1):57-9. PubMed ID: 19127957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical methods to promote drug delivery on mucosal tissues of the oral cavity.
    Giannola LI; Sutera FM; De Caro V
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1449-62. PubMed ID: 23802558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly disintegrating oramucosal drug delivery technologies.
    Reddy D; Pillay V; Choonara YE; du Toit LC
    Pharm Dev Technol; 2009; 14(6):588-601. PubMed ID: 19883248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Children's medicines in Tanzania: a national survey of administration practices and preferences.
    Adams LV; Craig SR; Mmbaga EJ; Naburi H; Lahey T; Nutt CT; Kisenge R; Noel GJ; Spielberg SP
    PLoS One; 2013; 8(3):e58303. PubMed ID: 23484012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.
    Zajicek A; Fossler MJ; Barrett JS; Worthington JH; Ternik R; Charkoftaki G; Lum S; Breitkreutz J; Baltezor M; Macheras P; Khan M; Agharkar S; MacLaren DD
    AAPS J; 2013 Oct; 15(4):1072-81. PubMed ID: 23907486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
    Batchelor HK; Kendall R; Desset-Brethes S; Alex R; Ernest TB;
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):833-42. PubMed ID: 23665448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancement in stimuli triggered in situ gelling delivery for local and systemic route.
    Ajazuddin ; Alexander A; Khan J; Giri TK; Tripathi DK; Saraf S; Saraf S
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1573-92. PubMed ID: 23075325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging studies in support of oral pediatric formulation development.
    Ricci BM
    Int J Pharm; 2013 Nov; 457(1):323-6. PubMed ID: 23942015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.
    Campbell GA; Vallejo E
    J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal drug delivery.
    Guy RH
    Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refining stability and dissolution rate of amorphous drug formulations.
    Grohganz H; Priemel PA; Löbmann K; Nielsen LH; Laitinen R; Mullertz A; Van den Mooter G; Rades T
    Expert Opin Drug Deliv; 2014 Jun; 11(6):977-89. PubMed ID: 24754747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.